Voices
Jeff Teuteberg: Early Cell-Free DNA Trajectories Correlate With Outcomes Based on KAOR Registry Data
Jeff Teuteberg/X

Jeff Teuteberg: Early Cell-Free DNA Trajectories Correlate With Outcomes Based on KAOR Registry Data

Jeff Teuteberg, CMO CareDx, shared a post on X:

“Early trajectories of cell free correlated with outcomes! Data from CareDx’s KAOR registry presented this am American Society of Transplantation.

American Transplant Congress (ATC) 2026 More evidence for insights from longitudinal data with protocol-based testing! Stay tuned for more evidence from the KAOR investigators.”

Jeff Teuteberg

Other articles about ATC 2026 on OncoDaily

American Society of Transplantation cancer CareDx Jeff Teuteberg KAOR KAOR registry OncoDaily Oncology